LEGN
Legend Biotech Corp
NASDAQ · Healthcare · Biotechnology · US
$17.61
+0.17%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- $0.02
- Revenue estimate
- $361.4M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- $0.09
- EPS estimate
- $0.12
- Revenue actual
- $387.5M
- Revenue estimate
- $356.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -151.7%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $48
- PT range
- $24 – $74
- Analysts
- 7
4 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | $0.12 | $0.09 | Miss -25.00% | $387.5M |
| May 12, 2026 | -$0.02 | -$0.15 | Miss -650.00% | $305.1M |
| Mar 10, 2026 | -$0.17 | -$0.08 | Beat 52.94% | $306.3M |
| Nov 12, 2025 | -$0.13 | -$0.11 | Beat 15.38% | $272.3M |
| Mar 11, 2025 | -$0.39 | -$0.15 | Beat 61.54% | $186.5M |
| Aug 9, 2024 | -$0.54 | -$0.05 | Beat 90.74% | $186.5M |
| Mar 11, 2024 | -$0.70 | -$0.40 | Beat 42.86% | $79.5M |
| Nov 20, 2023 | -$0.56 | -$0.17 | Beat 69.64% | $96.0M |
| Aug 15, 2023 | -$0.69 | -$0.27 | Beat 60.87% | $73.3M |
| May 18, 2023 | -$0.56 | -$0.40 | Beat 28.57% | $36.3M |
| Sep 30, 2022 | — | -$0.54 | — | $27.4M |
| Jun 1, 2022 | -$0.37 | -$0.24 | Beat 35.14% | $12.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026